Medical Thawing Device Delivers Plasma on Demand
|
By HospiMedica International staff writers Posted on 14 Jan 2020 |
|
Image: The ZipThaw device thaws plasma rapidly and safely (Photo courtesy of FreMon Scientific)
A portable rapid warming device thaws fresh frozen plasma (FFP) and plasma frozen within 24 hours after phlebotomy (FP24) for clinical use.
The FreMon Scientific (La Jolla, CA, USA) ZipThaw device is a lightweight (eight kilograms), compact precision plasma thawing system that is designed to rapidly thaw FFP and FP24 at the point of care, be it the operating room, procedure room, at the bedside, or in a trauma location. The device plugs into a standard outlet and has two chambers which work independently. Fear of cross contamination is minimized via the leakproof ZipSleeve, a disposable, durable, blood product sleeve that eliminates concerns of bursting bags, and also contains a warming technology that enables consistent temperature of the final product.
Features include dry electronic circuits, with no water immersion needed; preservation of coagulation factors needed for transfusion; a touch screen with a user friendly interface; the device is maintenance free, eliminating the risk of rupture and cross contamination; blood products temperature is consistently monitored, with no recalibration needed; continuous data capture and report of the full thawing cycle is provided; an integrated barcode reader promotes freezer-to-vein tracking; whisper quiet operation; and a three-year full replacement warranty.
“ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve's patented sensors, the system gives accurate, degree-by-degree measurement of the specimen's actual temperature during the thawing process, not its surroundings,” said Farideh Bischoff, MD, CEO of FreMon Scientific. “FreMon Scientific has designed the next generation thawing device. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible, and safe.”
Blood plasma is a yellowish-colored liquid component of blood in which blood cells are suspended, making it the “extracellular matrix” of blood cells. Along with platelets, plasma serves an important function and thanks to clotting factors, helps repair damage to blood vessels and stanching bleeding. FFP can be kept at -25°C or lower for up to three years, and can be used for five days after thawing. Civilian and military clinical practice guidelines call for early transfusion of plasma in cases of severe trauma and hemorrhagic shock so as to achieve a plasma-to-red-blood-cell ratio of 1:1 to 1:2.
Related Links:
FreMon Scientific
The FreMon Scientific (La Jolla, CA, USA) ZipThaw device is a lightweight (eight kilograms), compact precision plasma thawing system that is designed to rapidly thaw FFP and FP24 at the point of care, be it the operating room, procedure room, at the bedside, or in a trauma location. The device plugs into a standard outlet and has two chambers which work independently. Fear of cross contamination is minimized via the leakproof ZipSleeve, a disposable, durable, blood product sleeve that eliminates concerns of bursting bags, and also contains a warming technology that enables consistent temperature of the final product.
Features include dry electronic circuits, with no water immersion needed; preservation of coagulation factors needed for transfusion; a touch screen with a user friendly interface; the device is maintenance free, eliminating the risk of rupture and cross contamination; blood products temperature is consistently monitored, with no recalibration needed; continuous data capture and report of the full thawing cycle is provided; an integrated barcode reader promotes freezer-to-vein tracking; whisper quiet operation; and a three-year full replacement warranty.
“ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve's patented sensors, the system gives accurate, degree-by-degree measurement of the specimen's actual temperature during the thawing process, not its surroundings,” said Farideh Bischoff, MD, CEO of FreMon Scientific. “FreMon Scientific has designed the next generation thawing device. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible, and safe.”
Blood plasma is a yellowish-colored liquid component of blood in which blood cells are suspended, making it the “extracellular matrix” of blood cells. Along with platelets, plasma serves an important function and thanks to clotting factors, helps repair damage to blood vessels and stanching bleeding. FFP can be kept at -25°C or lower for up to three years, and can be used for five days after thawing. Civilian and military clinical practice guidelines call for early transfusion of plasma in cases of severe trauma and hemorrhagic shock so as to achieve a plasma-to-red-blood-cell ratio of 1:1 to 1:2.
Related Links:
FreMon Scientific
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Surgical System
Stealth AXiS
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
